Foghorn Therapeutics Inc. (FHTX) Capital expenditures 2019–2025
Foghorn Therapeutics Inc. (FHTX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$50,000FY2025 · since FY2019: $968,000 → $50,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $50,000 | -94.5% |
| FY2024 | $906,000 | -26.0% |
| FY2023 | $1.2M | +1.2% |
| FY2022 | $1.2M | -63.5% |
| FY2021 | $3.3M | -79.5% |
| FY2020 | $16.2M | +1571.8% |
| FY2019 | $968,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice